Testing New Criteria for Autoimmune Pancreas Inflammation
Part of Cancer, Digestive system, Hormones & metabolism, Immune system & allergy clinical trials.
This study validates a new diagnostic tool (Odesa Criteria 2026) to help doctors accurately identify autoimmune pancreatitis—a rare condition where the body attacks the pancreas. If you're being evaluated for possible pancreas inflammation, this trial may help confirm whether you have this specific type.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are being evaluated for suspected autoimmune pancreatitis (pancreas inflammation caused by your immune system)
- You have available medical records, blood tests, imaging scans, or tissue samples from your pancreas evaluation
- You can provide informed consent to participate
- You do not have a confirmed alternative diagnosis (like pancreatic cancer or pancreatitis from another cause)
- You have not had prior surgery on your pancreas
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how “inflammation” in the pancreas changes over time—going from a first or repeated attack to long-term (chronic) pancreatitis. It may help doctors understand what drives progression and identify people at higher risk for chronic disease.
This study keeps a medical registry of people with chronic pancreatitis (long-term pancreas inflammation), starting soon after the diagnosis. It helps doctors better understand how the condition begins and progresses in real life.
This study uses a special pain-testing method to better predict how people with chronic pancreatitis-related pain (or similar conditions) will respond to treatment. It may help doctors choose therapies that work better for each person’s type of pain.
This study looks at how the pancreas affects blood sugar and diabetes. It may help find better ways to prevent or treat type 2 diabetes.
This study looks at blood “markers” to find early signs or higher risk for pancreatic cancer. You may join if you have certain risk factors (like new diabetes, pancreatic cysts/pancreatitis, or a strong family history) and can come to Omaha for blood draws twice a year.
This study looks for proteins in the blood that could help doctors tell the difference between pancreatic cancer and non-cancerous pancreatic conditions, such as chronic pancreatitis or benign cysts. By participating, you could help improve early and accurate diagnosis, which may lead to better outcomes for future patients.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.